home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

280 rows where filing_period = "third_quarter", filing_year = 2021 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 280 ✖

filing_year 1

  • 2021 · 280 ✖

filing_period 1

  • third_quarter · 280 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2675418 LUNGREN LOPINA LLC e2c5bbea-923b-4487-819a-2c82c131aea4 Q3 LUNGREN LOPINA LLC 401103314 AMPAC FINE CHEMICALS 2021 third_quarter PHA Fair treatment for US based pharmaceutical ingredients Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-09-27T16:38:07.957000-04:00
2675966 RED+BLUE STRATEGIES 248c2449-bae5-4452-a830-60ecdd75b586 3T RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2021 third_quarter PHA PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2021-10-03T11:20:41.550000-04:00
2676066 AMERICAN COLLEGE OF CLINICAL PHARMACY c75f644f-7937-43e1-a672-d9019562331a Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 third_quarter PHA Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-10-04T10:02:17.787000-04:00
2676594 VICKI J HICKS df650e9b-fe60-4ac0-8694-40da89e5e04e Q3 VICKI J HICKS 401106146 A2 STRATEGIES, LLC OBO PHIBRO ANIMAL HEALTH CORPORATION 2021 third_quarter PHA Animal health issues. SENATE     0 0 2021-10-06T11:03:30.170000-04:00
2676663 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 94e8a2c0-2e88-4089-90c7-7e2b0dc42679 Q3 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2021 third_quarter PHA Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation. H.R. 1002 Debarment Enforcement of Bad Actor Registrants Act H.R. 1899 Ensuring Compliance Against Drug Diversion Act Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   370000 0 0 2021-10-06T12:09:49.377000-04:00
2676850 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 33a22331-4872-45eb-aa5f-4e16f2516a50 Q3 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 401103605 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 2021 third_quarter PHA COVID-19 vaccine & therapeutic production, and pandemic protection. Pharmaceutical supply chain and domestic manufacturing HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-10-07T09:38:56.130000-04:00
2676997 REPUBLIC CONSULTING, LLC 3625bf38-b6f0-40b5-b6b7-00866b8bb143 Q3 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 third_quarter PHA Monitored Health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-07T13:59:53.117000-04:00
2677367 STONINGTON GLOBAL 3b531f7c-1c4b-42b0-9c74-e757ddf53f93 Q3 STONINGTON GLOBAL 401105189 SORRENTO THERAPEUTICS, INC. 2021 third_quarter PHA Regulatory approvals and funding for pharmaceutical products and devices Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 150000   0 0 2021-10-08T13:55:06.893000-04:00
2677393 STONINGTON GLOBAL 446c48c7-1ad8-4d76-ab1e-3e7238e5202e 3T STONINGTON GLOBAL 401105189 NOSTRUM PHARMACEUTICALS LLC 2021 third_quarter PHA Issues affecting generic pharmaceutical manufacturers Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 1 2021-10-08T14:17:17.110000-04:00
2677485 INDEPENDENT PHARMACY COOPERATIVE 5c581cfe-d2f7-4842-a6b8-8ba85e4d93fa Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2021 third_quarter PHA IPC supports S. 1909/H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act. Support regulations/laws that would eliminate pharmacy DIR. IPC supports Pharmacists as Providers under Medicare Part B. IPC supports Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 2759/S. 1362 IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. IPC supports MCO Medicaid reform and elimination of spread pricing Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   30000 0 0 2021-10-08T17:13:53.780000-04:00
2677611 PENN AVENUE PARTNERS 3ea2815e-9ec5-48b8-97ca-ee782d9676e9 Q3 PENN AVENUE PARTNERS 400918672 ALKERMES, INC. 2021 third_quarter PHA Regulatory and legislative issues impacting Alkermes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-10T11:57:32.233000-04:00
2677664 PENN AVENUE PARTNERS 4e81ea50-cec0-4e31-8754-937dc7699d4f Q3 PENN AVENUE PARTNERS 400918672 UNITEDHEALTH GROUP, INC. 2021 third_quarter PHA Pharmacy benefit related issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 90000   0 0 2021-10-10T12:41:48.527000-04:00
2677717 RED+BLUE STRATEGIES 4bb74057-da1d-4629-a972-9f7fcb913240 Q3 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2021 third_quarter PHA Build Back Better Act - Support of full repeal of the Trump Administration's Rebate Rule. H.R. 3684 - INVEST in America Act - Support for delay of the Trump Administration's Rebate rule PL 117-2 - The American Rescue Plan Act - Implementation of policies related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-10-10T17:45:02.870000-04:00
2677742 RED+BLUE STRATEGIES 8858a006-cb0f-4089-a008-ae3d743d72ce Q3 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2021 third_quarter PHA Build Back Better Act - Issues related to supporting the growth of biosimilars in America to provide competition and tools to lower the cost of prescription medications Work to advance policies that support companies that fully manufacture products in America. S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-11T09:33:13.227000-04:00
2677863 POLSINELLI PC c56a41ca-ad49-477b-899f-50b09bc7c53e Q3 POLSINELLI PC 314911 TEVA PHARMACEUTICALS USA, INC. 2021 third_quarter PHA Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-11T14:17:55.427000-04:00
2678075 NATIONAL ADVOCACY CENTER OF THE SISTERS OF THE GOOD SHEPHERD 003da944-73d3-413b-b724-0cf05b01ad4f Q3 NATIONAL ADVOCACY CENTER OF THE SISTERS OF THE GOOD SHEPHERD 77993 CONFERENCE OF PROVINCIALS OF NORTH AMERICA 2021 third_quarter PHA Advocated to lower the cost of prescription drugs as part of the FY2022 Budget Resolution and in Build Back Better. Agriculture, Dept of (USDA),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Justice, Dept of (DOJ),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),Vice President of the U.S.,White House Office 40000   0 0 2021-10-11T16:17:43.907000-04:00
2678430 AMERICAN PHARMACISTS ASSOCIATION c529c99a-2a1a-447d-a4d7-c01659f7809b Q3 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2021 third_quarter PHA H.R. 3554/S.1909 The Pharmacy DIR Reform To Reduce Senior Drug Costs Act, to amend title XVIII of the Social Security Act to reform requirements with respect to direct and indirect remuneration under Medicare part D, and for other purposes. H.R. 3662 -- The Patient Access to Urgent-Use Pharmacy Compounding Act of 2021, to amend the Federal Food, Drug, and Cosmetic Act to ensure patients have access to certain urgent-use compounded medications, and for other purposes. H.R. 3682 --To amend title XI of the Social Security Act to provide greater transparency for discounts provided by manufacturers. H.R. 2608 --Ensuring Seniors Access to Local Pharmacies Act of 2021, a bill that establishes several requirements for prescription drug plans under the Medicare prescription drug benefit. HOUSE OF REPRESENTATIVES,SENATE   35000 0 0 2021-10-12T12:24:16.420000-04:00
2678556 PANNONE LOPES DEVEREAUX & O'GARA LLC 7aaf670f-2498-4d1d-a5ef-6183f6b789c5 Q3 PANNONE LOPES DEVEREAUX & O'GARA LLC 401105501 AMGEN 2021 third_quarter PHA Prescription drug pricing.   9000   0 0 2021-10-12T13:45:46.987000-04:00
2678885 MCDERMOTT+ LLC 03f11e99-0518-4f0c-b231-b257d8754b06 Q3 MCDERMOTT+ LLC 401103287 ALLIANCE FOR RURAL HOSPITAL ACCESS 2021 third_quarter PHA Amendments to Section 340B of the Public Health Service Act regarding eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program, including the Closing Loopholes for Orphan Drugs Act (H.R. 853). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-12T18:01:03.233000-04:00
2679215 ISEMAN & ASSOCIATES LLC 2528ad86-fe3b-4a85-8fde-6c9077a3a12c Q3 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2021 third_quarter PHA Monitoring biotech legislation; prescription drug prices; COVID- Relief legislation; Infrastructure Legislation; FY22 Appropriations bills HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-13T12:03:07.827000-04:00
2679289 MLJ STRATEGIES 794f689d-3f48-4c1d-96bf-26ab06c73e60 Q3 MLJ STRATEGIES 401105126 ANKURA CONSULTING GROUP, LLC ON BEHALF OF ON DEMAND PHARMACEUTICALS 2021 third_quarter PHA Advocating on issues related to pharmaceutical appropriations HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-13T13:30:29.443000-04:00
2679296 MLJ STRATEGIES 4d39bc6f-cc06-4c89-ba6a-5d9530d62251 Q3 MLJ STRATEGIES 401105126 ANKURA CONSULTING GROUP, LLC ON BEHALF OF THORNE RESEARCH 2021 third_quarter PHA Advocate on issues related to supplement use in the military HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-13T13:34:31.737000-04:00
2679653 CONNECT 4 STRATEGIES, LLC c0855fd6-afe8-476c-8705-3a2b542a6da6 Q3 CONNECT 4 STRATEGIES, LLC 401103720 OREXO US, INC. 2021 third_quarter PHA Legislative and regulatory issues pertaining to Orexo Implementation of the SUPPORT act. Access to Digital Therapeutics (S3532) MAT Digital Therapeutics Support Recovery Act. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-13T19:37:17.113000-04:00
2680508 FOLEY & LARDNER LLP bd48ed63-4c99-466a-8c28-173cface19bd Q3 FOLEY & LARDNER LLP 15042 BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY) 2021 third_quarter PHA Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-14T14:37:48.057000-04:00
2680625 FOLEY & LARDNER LLP 875b3d2f-5d28-4a21-9296-c2980e5aa947 Q3 FOLEY & LARDNER LLP 15042 ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY 2021 third_quarter PHA FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2021-10-14T15:30:18.290000-04:00
2680748 BOLD STRATEGIES, LLC 3a60c080-78ae-42e9-b955-4bb454565880 Q3 BOLD STRATEGIES, LLC 401104653 MORRIS & DICKSON CO., LLC 2021 third_quarter PHA Prescription drug issues generally. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-14T17:04:59.657000-04:00
2680904 FOLEY & LARDNER LLP 8374170c-c6e3-42cf-9e22-cc2d7e39cbfa Q3 FOLEY & LARDNER LLP 15042 FOUNDATION CONSUMER HEALTHCARE LLC 2021 third_quarter PHA Legislation and regulations affecting marketing and commercialization of prescription and non-prescription drugs HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2021-10-14T21:08:52.990000-04:00
2680907 ACG ADVOCACY 25b8deaf-bdfa-433f-a9a7-8a75b09d6b20 Q3 ACG ADVOCACY 2057 WALGREEN CO. 2021 third_quarter PHA Drug Pricing Policy Issues. Data privacy and DIR fee reform. Counterfeiting Issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-14T21:10:54.097000-04:00
2681020 TODD STRATEGY GROUP 6c003377-d233-4902-8737-f21fd1db5463 Q3 TODD STRATEGY GROUP 401103321 ALKERMES, INC. 2021 third_quarter PHA Prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T08:06:34.127000-04:00
2681059 TODD STRATEGY GROUP d728036f-f8a7-4953-9aeb-29ab21eacd48 Q3 TODD STRATEGY GROUP 401103321 ASTRAZENECA PHARMACEUTICALS LP 2021 third_quarter PHA Drug pricing. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-15T09:25:44.177000-04:00
2681060 TODD STRATEGY GROUP c50e6701-37d7-4c2a-ad6d-54b0536f9543 Q3 TODD STRATEGY GROUP 401103321 BAYER CORPORATION 2021 third_quarter PHA Drug pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T09:28:44.743000-04:00
2681073 TODD STRATEGY GROUP b78f988f-2dba-400f-b0f8-36be09077ccf Q3 TODD STRATEGY GROUP 401103321 BIOTECHNOLOGY INNOVATION ORGANIZATION 2021 third_quarter PHA Drug pricing and access. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2021-10-15T09:40:48.793000-04:00
2681074 TODD STRATEGY GROUP c39b7c8c-1950-4fa2-ac62-beea8db62ef6 Q3 TODD STRATEGY GROUP 401103321 CAREDX, INC. 2021 third_quarter PHA Immunosuppressive drug coverage implementation. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 40000   0 0 2021-10-15T09:41:49.363000-04:00
2681077 NELSON MULLINS RILEY & SCARBOROUGH 7b37a819-003d-4a88-bdb9-56f4b4abbb70 Q3 NELSON MULLINS RILEY & SCARBOROUGH 285871 HEMOPHILIA OF GEORGIA 2021 third_quarter PHA 340B Drug Pricing Program, Medicare, biomedical research, ACA implementation and COVID-19 response and relief legislation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-15T09:46:50.440000-04:00
2681114 LINCOLN PARK GROUP L.L.C. dc811b3c-4bfc-4c46-89bb-94e5988fe2bd Q3 LINCOLN PARK GROUP L.L.C. 401104374 CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2021 third_quarter PHA Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-15T10:11:01.400000-04:00
2681144 TODD STRATEGY GROUP 6b5c2cb5-84dd-40de-8e48-ae7d88a7b288 Q3 TODD STRATEGY GROUP 401103321 EMD SERONO INC. 2021 third_quarter PHA Drug pricing policy. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T10:18:07.857000-04:00
2681164 TODD STRATEGY GROUP 46cc416b-ee40-418f-82a2-6f3bb5a5a8c3 Q3 TODD STRATEGY GROUP 401103321 GENENTECH, INC. 2021 third_quarter PHA Prescription drug payment reform. Supply chain. Strategic National Stockpile. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-15T10:22:12.460000-04:00
2681205 TODD STRATEGY GROUP 72212c13-2eee-43bc-a74b-9c01b66a0058 Q3 TODD STRATEGY GROUP 401103321 MERCK & CO., INC. 2021 third_quarter PHA Drug Pricing. 340B Issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-15T10:35:23.847000-04:00
2681209 TODD STRATEGY GROUP 8f8b7488-7287-43e8-a879-b7a9d2287f51 Q3 TODD STRATEGY GROUP 401103321 NOVARTIS, INC. 2021 third_quarter PHA Drug Pricing. Supply Chain. 340B Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T10:40:25.810000-04:00
2681223 TODD STRATEGY GROUP e37012ae-4da2-47ca-9f01-15f2f0bff617 Q3 TODD STRATEGY GROUP 401103321 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 third_quarter PHA Drug Pricing and Access. Pharmaceutical Supply Chain. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-15T10:43:29.550000-04:00
2681251 UNIVERSITY OF IOWA e54be645-16c7-4735-89a7-a846cbb561ec Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2021 third_quarter PHA Support for National Center of Excellence in Advanced and Continuous Pharmaceutical Manufacturing legislation Agriculture, Dept of (USDA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   60000 0 0 2021-10-15T10:46:32.843000-04:00
2681473 BALLARD PARTNERS 95663fe8-3130-4491-87fb-e18632b3c30a Q3 BALLARD PARTNERS 401104288 THE CRANEWARE GROUP (F.K.A. SENTRY DATA SYSTEMS) 2021 third_quarter PHA 340B Drug Discount Program. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-15T12:02:35.457000-04:00
2681485 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 169df1f1-0e58-410d-bdb2-bbe86c75c22a Q3 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2021 third_quarter PHA 340B Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   31485 0 0 2021-10-15T12:07:40.287000-04:00
2681495 KOUNTOUPES DENHAM CARR & REID, LLC 3700fff0-d18a-4c7c-9d95-cbf12831bbbf Q3 KOUNTOUPES DENHAM CARR & REID, LLC 320918 GLENMARK PHARMACEUTICALS, INC., USA 2021 third_quarter PHA Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T12:10:43.697000-04:00
2681599 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION ddfc45b6-83fa-438d-b236-fd6679a625b9 Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2021 third_quarter PHA S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution; Pharmacist scope of practice, including authorities established by the Public Readiness and Emergency Preparedness (PREP) Act; H.R. 4390, the PROTECT 340B Act of 2021; S. 1574, the Long-Term Care Pharmacy Definition Act of 2021; Provider Relief Fund; Implementation of Pubic Law 113-54, the Drug Quality and Security Act; Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Occupational Safety & Health Administration (OSHA),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office   420000 0 0 2021-10-15T13:05:07.690000-04:00
2681796 PUBLIC CITIZEN 159a4999-edab-4d0e-8b1c-7d1225b030f9 Q3 PUBLIC CITIZEN 32362 PUBLIC CITIZEN 2021 third_quarter PHA HR3778/S 1976 (NOVID Act); Covid-19 Vaccine manufacturing and access and related funding, HR 3 (Lower Drug Costs Now Act, Senate Finance Drug price reform package, Aducanumab, Drug pricing, Insulin affordability for all Act, Medicare Negotiation and Competitive Licensing Act, We PAID Act, S. 1435-Affordable Prescriptions for Patients Act, Vaccine manufacturing and NDAA Consumer Product Safety Commission (CPSC),Equal Employment Opportunity Commission (EEOC),Federal Accounting Standards Advisory Board (FASAB),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE,Treasury, Dept of,White House Office   80000 0 0 2021-10-15T14:38:47.207000-04:00
2681843 BROWN & FORTUNATO, P.C. e5b0bc3a-7857-4f26-8a50-2c58f6b78da2 Q3 BROWN & FORTUNATO, P.C. 401104878 PROMPTCARE COMPANIES, INC. 2021 third_quarter PHA Issues related to Medicare home infusion therapy benefit and other health care issues. Issues related to the Medicare DMEPOS competitive bidding program and Medicare coverage and payment for non-invasive ventilators. Centers For Medicare and Medicaid Services (CMS) 20000   0 0 2021-10-15T14:46:55.773000-04:00
2682354 AMERICAN VETERINARY MEDICAL ASSOCIATION 9c734d76-dd36-4042-9aaa-efd8ad1447fd Q3 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2021 third_quarter PHA Prescription Mandate legislation Compounding Guidance (GFI 256) Agriculture, Dept of (USDA),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 210000   0 0 2021-10-15T21:26:03.973000-04:00
2682536 BLUE CROSS AND BLUE SHIELD ASSOCIATION b19dc5fe-625e-4628-a695-92228b66eaea Q3 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2021 third_quarter PHA COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform; H.R. 550 - Immunization Infrastructure Modernization Act of 2021 Sponsor: Rep. Annie Kuster (D-NH-02) H.R. 951 - Maternal Vaccination Act Sponsor: Rep. Terri Sewell (D-AL-07) H.R. 2347 - Strengthening the Vaccines for Children Program Act of 2021 Sponsor: Rep. Kim Schrier (D-WA-08) H.R. 3742 - Vaccine INFO Act Sponsor: Rep. Gus Bilirakis (R-FL-12) H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06) H.R. 2355 - Opioid Prescription Verification Act of 2021 Sponsor: Rep. Rodney David (R-IL-13) Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,White House Office   1350000 0 0 2021-10-16T05:14:43.767000-04:00
2682555 MARSHALL & POPP, LLC a3df2660-d18e-4b67-86cf-7312571df5c8 Q3 MARSHALL & POPP, LLC 401105121 AMGEN USA INC. 2021 third_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act; Budget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14. Issues related to supply chains, 340B, and the COVID-19 pandemic. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T08:51:29.393000-04:00
2682558 MARSHALL & POPP, LLC 3be130e4-ba5b-4e81-bfaa-e63b0107e3c2 Q3 MARSHALL & POPP, LLC 401105121 BUTTERFLY NETWORK, INC. 2021 third_quarter PHA Issues related to medical device manufacturing / insurance / technology. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T08:58:29.997000-04:00
2682574 MARSHALL & POPP, LLC f83c1fac-7221-416c-b040-03f86a362f4b Q3 MARSHALL & POPP, LLC 401105121 GENENTECH, INC. 2021 third_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; Budget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T09:14:34.210000-04:00
2682588 MARSHALL & POPP, LLC 36379c31-fa0e-408c-b3eb-8918f279216c Q3 MARSHALL & POPP, LLC 401105121 PFIZER, INC. 2021 third_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; Budget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T09:25:38.690000-04:00
2682594 MARSHALL & POPP, LLC 91162211-0aa7-411d-b8f0-d88ee7545097 Q3 MARSHALL & POPP, LLC 401105121 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2021 third_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S. 2164, the Lower Costs, More Cures Act; Budget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T09:29:39.803000-04:00
2682601 MARSHALL & POPP, LLC 44afd58b-0f40-462b-93c8-71022e394e63 Q3 MARSHALL & POPP, LLC 401105121 SANOFI U.S. SERVICES, INC. 2021 third_quarter PHA Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R.22/S.2164, the Lower Costs, More Cures Act; Budget reconciliation recommendations reported by House committees pursuant to S.Con.Res. 14. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T09:32:41.543000-04:00
2682815 GOVERNMENT COUNSEL, LLC 546c6f2e-c1d5-49de-8c1d-f7a6e0b042f5 Q3 GOVERNMENT COUNSEL, LLC 401105070 HEALTHCARE DISTRIBUTION ALLIANCE 2021 third_quarter PHA H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; Policies related to ARCOS data and suspicious order record requirements; Implementation of Public Law 113-54 (DSCSA). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T13:49:04.577000-04:00
2683160 CAPITOL COUNSEL LLC 504e615d-c9be-44d7-b953-aa6a7638a7d3 Q3 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 third_quarter PHA Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-16T19:53:30.727000-04:00
2683263 FORBES-TATE 59786460-4ea0-4226-83f8-7eb256239856 Q3 FORBES-TATE 400976792 INDEPENDENT PHARMACY COOPERATIVE 2021 third_quarter PHA Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-17T11:49:08.777000-04:00
2683909 MEHLMAN CONSULTING, INC. d207093d-26aa-471c-a1bc-1d48d99ec587 Q3 MEHLMAN CONSULTING, INC. 284950 AMNEAL 2021 third_quarter PHA Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Pandemic Preparedness. The Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2021-10-18T09:37:51.060000-04:00
2683938 MEHLMAN CONSULTING, INC. 29c1dd4d-8c36-4442-8a43-0a8e22a15a94 Q3 MEHLMAN CONSULTING, INC. 284950 ASCENSION HEALTH ALLIANCE 2021 third_quarter PHA 340B Drug Pricing Program. Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, access to PPE and other materials and equipment related to the treatment of patients with COVID-19. The Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T09:44:58.323000-04:00
2683947 MEHLMAN CONSULTING, INC. 8ea90ca2-9432-4d22-b6b6-a6ca4bc75bdd Q3 MEHLMAN CONSULTING, INC. 284950 BLUE SHIELD OF CALIFORNIA 2021 third_quarter PHA Prescription drug pricing. The Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T09:48:00.907000-04:00
2684159 MEHLMAN CONSULTING, INC. 4094bd0e-dbac-41bb-be1e-29eea35ef496 Q3 MEHLMAN CONSULTING, INC. 284950 THE CAMPAIGN FOR SUSTAINABLE RX PRICING 2021 third_quarter PHA S.1391 - Fair Accountability and Innovative Research Drug Pricing Act. Prescription drug pricing issues. Patent abuse issues. Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021. Drug-price Transparency for Competition (DTC) Act. The Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 110000   0 0 2021-10-18T10:33:53.350000-04:00
2684179 AARP 5c3e7275-f994-4ffa-b0ca-d05d21a626d3 Q3 AARP 1694 AARP 2021 third_quarter PHA H.R. 5376 Build Back Better Act. No bill number. Discussed prescription drugs prices and costs and Medicare. H.R. 4356, Agriculture, Rural Development Appropriations Act, FY 2022. S. 1428, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1287, the REFUND Act. Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office   2980000 0 0 2021-10-18T10:37:55.780000-04:00
2684230 MEHLMAN CONSULTING, INC. 830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95 Q3 MEHLMAN CONSULTING, INC. 284950 VIZIENT INC 2021 third_quarter PHA Issues related to Unapproved Drug Initiative. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2021-10-18T10:50:09.973000-04:00
2684279 WATKINS & EAGER PLLC 98120117-54e1-4674-9044-931ce97af690 Q3 WATKINS & EAGER PLLC 401104403 ZYNERBA PHARMACEUTICALS, INC. 2021 third_quarter PHA Providing services on behalf of Zynerba to the pharmaceutical industry Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-10-18T10:59:21.243000-04:00
2684283 WAXMAN STRATEGIES aa7d8769-bde2-45a3-ad63-04dfb09367d4 Q3 WAXMAN STRATEGIES 401103693 340B HEALTH 2021 third_quarter PHA Issues affecting the 340B drug pricing program; Appropriations for 340B program. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-10-18T10:59:21.750000-04:00
2684659 BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 89c7f8ed-ccb8-495e-ace3-869d045caf65 Q3 BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 401104621 BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 2021 third_quarter PHA HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances HOUSE OF REPRESENTATIVES,SENATE,White House Office   100000 0 0 2021-10-18T12:03:00.890000-04:00
2684820 FORBES-TATE 644c826f-f452-4042-8235-dde0167ed442 Q3 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 third_quarter PHA Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T12:26:40.670000-04:00
2685174 CORNERSTONE GOVERNMENT AFFAIRS, INC. 09824afa-ff19-49f7-81f1-3f27f93e467b Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 VYRIPHARM ENTERPRISES, INC. 2021 third_quarter PHA Policies and regulations associated with testing, tracing and tracking of cannabinoids. HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE 30000   0 0 2021-10-18T14:01:21.610000-04:00
2685301 FORBES-TATE 9adcf7df-0924-43ac-82bd-f530fc32d657 Q3 FORBES-TATE 400976792 MERCK 2021 third_quarter PHA Issues related to prescription drug pricing, vaccines, animal health, and maternal health. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T14:27:50.743000-04:00
2685646 TARPLIN, DOWNS & YOUNG, LLC 025d29dd-3015-4af5-b399-5e9fb27be353 Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2021 third_quarter PHA Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-18T14:50:48.073000-04:00
2685824 FORBES-TATE f457df06-815e-4441-9e06-fc422b1667d0 Q3 FORBES-TATE 400976792 PHRMA 2021 third_quarter PHA Issues pertaining to prescription drug pricing. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-18T15:09:26.693000-04:00
2685995 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION b227d517-6264-4c06-980d-db34be734d54 Q3 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2021 third_quarter PHA OTC switch process -- no bill number Cures 2.0 -- no bill number S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   133000 0 0 2021-10-18T15:26:05.173000-04:00
2686418 SUSAN B ANTHONY LIST aeae88ed-97c3-4d77-9625-a2d2fed5ecb5 Q3 SUSAN B ANTHONY LIST 400935704 SUSAN B ANTHONY LIST 2021 third_quarter PHA H.R. 554, S. 78 Support and Value Moms and Babies Act; Chemical abortion Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2021-10-18T16:13:33.260000-04:00
2686512 TARPLIN, DOWNS & YOUNG, LLC b0c49244-04c1-43e8-8e8f-355008fd822d Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2021 third_quarter PHA H.R. 1319, American Rescue Plan of 2021 implementation no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2021-10-18T16:27:57.893000-04:00
2686744 WINNING STRATEGIES WASHINGTON 60ebd16e-cbe7-4ede-aa95-c10789192e5c Q3 WINNING STRATEGIES WASHINGTON 50796 KALEO 2021 third_quarter PHA Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-18T17:06:53.627000-04:00
2686776 HANCE SCARBOROUGH b26d9696-4e6e-477c-abe0-6a6fc1e5cb6d Q3 HANCE SCARBOROUGH 17443 BOEHRINGER INGELHEIM USA CORPORATION 2021 third_quarter PHA Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-18T17:18:00.967000-04:00
2686801 HANCE SCARBOROUGH 4a01986b-27c3-4cd5-a31a-e60a04a92216 Q3 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2021 third_quarter PHA Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations HR3662, the Patient Access to Urgent Use Compounded Medication Act HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-18T17:25:06.193000-04:00
2686810 BROWNSTEIN HYATT FARBER SCHRECK, LLP b9014dc0-e00a-4d03-9e69-61f96b4ce868 Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 AIPHARMA GLOBAL HOLDINGS LIMITED 2021 third_quarter PHA Issues related to the pharmaceutical supply chain Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 80000   0 0 2021-10-18T17:28:08.097000-04:00
2686841 HANCE SCARBOROUGH c24ef9e9-c2cf-4fec-b079-ee00d306acef Q3 HANCE SCARBOROUGH 17443 PHRMA 2021 third_quarter PHA Patent reform regarding pharmaceutical research & products. SENATE 30000   0 0 2021-10-18T17:37:14.677000-04:00
2686846 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 24e32f99-8678-4843-8be7-9bd1fd91a211 Q3 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 401104060 THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH 2021 third_quarter PHA General education around pharmaceuticals related to Parkinson's disease Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   52751 0 0 2021-10-18T17:37:15.593000-04:00
2686874 KOUNTOUPES DENHAM CARR & REID, LLC c677cea8-e9ce-4202-a7ba-17eb77b024b7 Q3 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) 2021 third_quarter PHA Issues related to proposals that would address drug shortages and national stockpile issues, including H.R. 2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to COVID-19 vaccine distribution. Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to pharmacy provider status. Issues related to oncology medicines in H.R. 5067, the Preserving Patient Access to Home Infusion Act. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2021-10-18T17:50:21.420000-04:00
2687250 KNIGHT CAPITOL CONSULTANTS 6c204db0-76ba-4575-8365-38b582889bab Q3 KNIGHT CAPITOL CONSULTANTS 40036301 EQUASHIELD, LLC 2021 third_quarter PHA Provisions affecting vial reuse being discussed in connection with drug pricing legislation (H.R. 5376, Build Back Better Act). Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-18T21:18:53.907000-04:00
2687294 KNIGHT CAPITOL CONSULTANTS bd357551-47b2-4c50-96d2-919b0c79a27c Q3 KNIGHT CAPITOL CONSULTANTS 40036301 REGENXBIO 2021 third_quarter PHA Possible legislation which may affect Food and Drug Administration review of biologic products (no specific bill) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-18T21:43:03.370000-04:00
2687303 WEST FRONT STRATEGIES LLC 9dcb06e3-7553-46f0-aacc-0be30e7009d3 Q3 WEST FRONT STRATEGIES LLC 401103493 WALGREEN CO. 2021 third_quarter PHA Issues related to COVID-19 vaccination programs; issues related to pharmacy, pharmacist provider status, and Medicare reimbursement. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T21:55:06.483000-04:00
2687340 FLYNN & ASSOCIATES, INC. 6245f9ed-c797-4d92-ba0c-bd7b662fb8b2 Q3 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2021 third_quarter PHA H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-18T22:32:14.263000-04:00
2687813 VAN SCOYOC ASSOCIATES 316fa875-1e94-410b-ab2b-6c2341de1a40 Q3 VAN SCOYOC ASSOCIATES 39837 ZEBRA TECHNOLOGIES CORP. 2021 third_quarter PHA Temperature monitoring technology for COVID-19 vaccines, Domestic and International distribution related issues Temperature monitoring technology, generally HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-19T05:32:00.937000-04:00
2687882 BROYDRICK & ASSOCIATES f77ff540-32d3-4b2b-bf38-6a930fc75da9 Q3 BROYDRICK & ASSOCIATES 7268 EXELA PHARMA SCIENCES 2021 third_quarter PHA Drug shortages and FDA approval, USTR acceptance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-19T06:35:15.933000-04:00
2687911 BROYDRICK & ASSOCIATES 8abcfded-18ed-48e9-82b9-4114531a7b38 Q3 BROYDRICK & ASSOCIATES 7268 TONIX PHARMACEUTICALS 2021 third_quarter PHA Funding new drug for PTSD and COVID 19. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-19T06:49:26.830000-04:00
2688016 MASSACHUSETTS MEDICAL SOCIETY 68af04a9-4366-400c-a0bb-72c5d5e29dc7 Q3 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2021 third_quarter PHA Issues related to prescription drug prices - no specific bill Issues related to vaccines - no specific bill Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office   50000 0 0 2021-10-19T08:34:59.760000-04:00
2688248 TARPLIN, DOWNS & YOUNG, LLC 1e0e8337-b35b-4214-b18b-08b9df1778a0 Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2021 third_quarter PHA Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-19T09:17:45.540000-04:00
2688451 ELI LILLY AND COMPANY 9ae26008-a4a1-4795-8f34-2645e9954c25 Q3 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2021 third_quarter PHA Hospital discounts; 340B program Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1320000 0 0 2021-10-19T09:41:40.167000-04:00
2688550 CRISPR THERAPEUTICS, INC. 80a30d2a-42af-444f-afb5-73e4f624442a Q3 CRISPR THERAPEUTICS, INC. 401105184 CRISPR THERAPEUTICS, INC. 2021 third_quarter PHA Coverage & reimbursement for Cell and Gene Therapies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-10-19T09:51:07.977000-04:00
2688769 M.J. SIMON & COMPANY, LLC f345b90a-2cd0-48fc-9d86-6278b01e676f Q3 M.J. SIMON & COMPANY, LLC 40026223 NOBELPHARMA AMERICA 2021 third_quarter PHA FDA inspections HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-19T10:09:52.907000-04:00
2688890 TWENTY-FIRST CENTURY GROUP, INC. 8b3deb0e-803e-4166-81a7-c80287090924 Q3 TWENTY-FIRST CENTURY GROUP, INC. 38687 CARDINAL HEALTH, INC. 2021 third_quarter PHA Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; COVID-19pandemic response; and the healthcare supply chain. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-19T10:19:17.687000-04:00
2688893 BUCHANAN INGERSOLL & ROONEY PC 2f4f19d3-0618-4c28-b306-fbaa5d725cc5 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2021 third_quarter PHA Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-19T10:19:18.140000-04:00
2689171 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 2b552729-dd3b-4d3a-abd4-668d34fc751a Q3 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 39121 UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 2021 third_quarter PHA Met with Senate staff regarding prescription drug reform. HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2021-10-19T10:45:09.630000-04:00
2689452 KOUNTOUPES DENHAM CARR & REID, LLC 86af380f-7bc7-4de6-a56a-2ea7b94f9b58 Q3 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CVS HEALTH 2021 third_quarter PHA General education about the pharmacy benefit manager/pharmacy and insurance industry. Issues related to drug pricing. Issues related to the drug supply chain. Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to the implementation of H.R. 1319, The American Rescue Plan, including provisions related to vaccine distribution. Issues related to the Fiscal Year 2022 budget reconciliation process focusing on drug pricing. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-19T11:17:06.287000-04:00
2689453 FORBES-TATE 0c7986fe-e86d-4773-8b62-20f525a28681 Q3 FORBES-TATE 400976792 VERDE TECHNOLOGIES 2021 third_quarter PHA Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-19T11:17:06.720000-04:00
2689595 SUMMIT PUBLIC AFFAIRS 58cfb562-72f6-4181-927e-0a8f892e24da Q3 SUMMIT PUBLIC AFFAIRS 401105467 VANDA PHARMACEUTICALS INC. 2021 third_quarter PHA Issues affecting the pharmaceutical industry, including the prescription drug approval process. 21st Century Cures Act 2.0 (proposed legislation). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-19T11:31:44.320000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2191.826ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API